Parathyroid Carcinoma Clinical Trial
Official title:
Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior
Objectives:
1. Identify the clinical characteristics of parathyroid (PTH) cancer and PTH atypical
neoplasms
2. Investigate if PTH carcinoma and atypical neoplasm present a biological behaviour and
have a different impact on the health of the patients
Data between the years of 1/1/2002 and 12/31/2013 will be analyzed. The medical records of all adult patients that had a parathyroidectomy for primary PHPT in MD Anderson Cancer Center will be screened in order to identify patients that had a histopathological diagnosis of parathyroid carcinoma or atypical parathyroid neoplasm. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00580320 -
Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
|
Phase 1 | |
| Completed |
NCT01460030 -
An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
|
Phase 3 | |
| Recruiting |
NCT05789680 -
European Multicentric Study on Parathyroid Carcinoma
|
||
| Completed |
NCT03280264 -
Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
|
Phase 3 |